International Congress of Virology, Istanbul, ASV Travel Request

国际病毒学大会，伊斯坦布尔，ASV 旅行请求

• 批准号: 7329459
• 负责人: DOROTHEA L SAWICKI
• 金额: $ 3万
• 依托单位: UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-02-01 至 2009-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7329459
• 关键词: Acquired Immunodeficiency Syndrome; Address; American; Animals; Area; Award; Biotechnology; Cardiovascular system; Childhood; Chronic; Clinical Virology; Collaborations; Congresses; Coronavirus; Country of Turkey; Degenerative Disorder; Development; Diagnosis; Disease; Educational workshop; Evolution; Family; Funding; Future; Genetic; Genomics; Goals; Grant; HIV; Hepatitis; Host Defense; Human Virus; Immunobiology; Immunologics; Influenza; Insecta; Integration Host Factors; International; Learning; Lung; Methods; Minority; Neurologic; Oncolytic; Parvovirus; Pathogenesis; Plants; Prokaryotic Cells; Research; Research Personnel; Scientist; Severe Acute Respiratory Syndrome; Societies; Structure; Travel; Vaccines; Viral; Virus; Virus Replication; Virus-Cell Membrane Interaction; Woman; Work; abstracting; base; gastrointestinal; gene therapy; neoplastic; novel strategies; posters; symposium; virology; virus pathogenesis

Abstract The American Society for Virology (ASV) wishes to provide, through this block grant, partial support for the travel of 20 selected outstanding junior virologists to participate in the XIVth International Congress of Virology (ICV) to be held August 11-15, 2008, at a level of $1,500 per award, for a $30,000 total. This triennial ICV will be in Istanbul, Turkey, and it is essential for the U.S. to be represented by its best junior virologists. The ICV is a unique opportunity for U.S. junior investigators to meet and interact directly with internationally recognized expert virologists as well as learn in plenary sessions, workshops and poster sessions the most recent developments in all virus research areas, including viruses of humans, animals, plants, insects, and prokaryotes. Current problems in clinical virology, AIDS and SARS, and newly recognized parvoviruses and coronaviruses, will be included. Plenary sessions will cover virus entry and structure, virus-cell interactions, evolution, immunobiology, pathogenesis, virus versus host defenses, virus replication and host factors for replication, and emerging viruses and the control of viruses. There will also be special topics symposia that focus on new methods in viral diagnosis, new approaches to developing vaccines, gene therapy and delivery, and viruses as oncolytic agents. Workshop and poster sessions will address all virus families and their replication and pathogenesis, including HIV, hepatitis, influenza, and coronaviruses. The ASV considers one excellent way to stimulate and aid junior virologists in their future work is to enable them to interact directly with the best virologists world-wide, from which unique, long-lasting collaborations often result. Dr. Donald Ganem, ASV President, will appoint a selection committee to judge who among the applicants will receive partial travel support based on (1) ICV participation, (2) prospect that the awardee's research will benefit, and (3) financial need. The selection committee will include among others, Dr. Dorothea Sawicki, Scientific Director of this application and Secretary-Treasurer of the ASV. A satisfactory post-meeting report detailing the benefits to their research will be required of successful applicants. Our aim is to provide partial funding for junior virologists, including women and minority scientists, who might otherwise be unable to attend the ICV, with the goal of benefiting virological research in the U.S. for years to come. Virological research has many applications in the fields of infectious, immunologic, neoplastic, hematologic, pulmonary, cardiovascular, gastrointestinal, neurologic, ophalmologic, developmental and childhood diseases, and in chronic and degenerative diseases, as well as in basic genetics, genomics, gene therapy and biotechnology. C:\Documents and Settings\ASV\Grant\ICV-2008\ICV Abstract.doc

抽象的 美国病毒学协会 (ASV) 希望通过这笔整笔拨款提供： 部分支持20名入选的优秀初级病毒学家参加的旅行 第十四届国际病毒学大会 (ICV) 将于 2008 年 8 月 11 日至 15 日在 每个奖项的金额为 1,500 美元，总计 30,000 美元。三年一度的 ICV 将在伊斯坦布尔举行， 土耳其，美国也必须有最优秀的初级病毒学家代表。 ICV 为美国初级研究人员提供了直接会面和互动的独特机会 与国际公认的专家病毒学家一起学习，并在全体会议上学习， 研讨会和海报会议所有病毒研究的最新进展 领域，包括人类、动物、植物、昆虫和原核生物的病毒。当前的 临床病毒学、艾滋病和非典以及新认识的细小病毒和 冠状病毒，将被包括在内。全体会议将讨论病毒的进入和结构， 病毒与细胞相互作用、进化、免疫生物学、发病机制、病毒与宿主 防御、病毒复制和复制的宿主因素以及新出现的病毒和 控制病毒。还将举办专题研讨会，重点关注新领域 病毒诊断方法、开发疫苗的新方法、基因治疗和 递送和病毒作为溶瘤剂。研讨会和海报会议将讨论 所有病毒家族及其复制和发病机制，包括艾滋病毒、肝炎、 流感和冠状病毒。 ASV 认为一种极好的方式来刺激和 在未来的工作中帮助初级病毒学家的目的是使他们能够直接与病毒学家互动 世界各地最好的病毒学家，往往会产生独特、持久的合作。 ASV 主席 Donald Ganem 博士将任命一个遴选委员会来评判谁 其中申请人将根据 (1) 参与智能网联汽车获得部分旅行支持， (2) 预期获奖者的研究将受益，以及 (3) 财务需求。这 评选委员会将包括科学主任 Dorothea Sawicki 博士 本申请的负责人和 ASV 的秘书兼财务主管。满意的会后 成功的申请者将需要一份详细说明其研究的好处的报告。 我们的目标是为初级病毒学家提供部分资金，包括女性和少数民族 科学家，否则他们可能无法参加 ICV，目的是使他们受益 未来几年美国的病毒学研究。病毒学研究有很多 在感染、免疫、肿瘤、血液、肺、 心血管、胃肠、神经、眼科、发育和儿童 疾病、慢性病和退行性疾病以及基础遗传学， 基因组学、基因治疗和生物技术。 C:\Documents and Settings\ASV\Grant\ICV-2008\ICV Abstract.doc